日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A sensitive and specific assay to characterize plasma kallikrein activity in plasma from patients with hereditary angioedema

一种灵敏且特异的检测方法,用于表征遗传性血管性水肿患者血浆中的激肽释放酶活性。

Lee, Daniel K; Ghannam, Arije; Murugesan, Nivetha; Vincent, Denis; Dona, Micaela; Cohn, Danny M; Adatia, Adil; Smith, Michael D; Audhya, Paul K; Hampton, Sally L; Feener, Edward P

A mechanism for hereditary angioedema caused by a methionine-379-to-lysine substitution in kininogens

激肽原中甲硫氨酸-379 被赖氨酸取代引起的遗传性血管性水肿的机制

Dickeson, S Kent; Kumar, Sunil; Sun, Mao-Fu; Litvak, Maxim; He, Tracey Z; Phillips, Dennis R; Roberts, Elijah T; Feener, Edward P; Law, Ruby H P; Gailani, David

A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination

一项随机双盲试验旨在评估接种 COVID-19 mRNA 疫苗后全身性过敏反应的复发情况。

Khalid, Muhammad B; Zektser, Ellen; Chu, Eric; Li, Min; Utoh, Joanna; Ryan, Patrick; Loving, Hanna S; Harb, Roa; Kattappuram, Robbie; Chatman, Lindsay; Hartono, Stella; Claudio-Etienne, Estefania; Sun, Guangping; Feener, Edward P; Li, Zhongbo; Lai, Samuel K; Le, Quang; Schwartz, Lawrence B; Lyons, Jonathan J; Komarow, Hirsh; Zhou, Zhao-Hua; Raza, Haniya; Pao, Maryland; Laky, Karen; Holland, Steven M; Brittain, Erica; Frischmeyer-Guerrerio, Pamela A

Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease

更新糖尿病视网膜疾病分期系统所考虑的基本和细胞机制的理论依据

Hartnett, M Elizabeth; Fickweiler, Ward; Adamis, Anthony P; Brownlee, Michael; Das, Arup; Duh, Elia J; Feener, Edward P; King, George; Kowluru, Renu; Luhmann, Ulrich F O; Storti, Federica; Wykoff, Charles C; Aiello, Lloyd Paul

Titanium is a potent inducer of contact activation: implications for intravascular devices

钛是接触激活的强效诱导剂:对血管内装置的意义

Litvak, Maxim; Shamanaev, Aleksandr; Zalawadiya, Sandip; Matafonov, Anton; Kobrin, Anton; Feener, Edward P; Wallisch, Michael; Tucker, Erik I; McCarty, Owen J T; Gailani, David

Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema

KVD900是一种口服的血浆激肽释放酶抑制剂,可用于按需治疗遗传性血管性水肿,其通过药理学手段抑制激肽释放酶-激肽系统。

Duckworth, Edward J; Murugesan, Nivetha; Li, Lily; Rushbrooke, Louise J; Lee, Daniel K; De Donatis, Gian Marco; Maetzel, Andreas; Yea, Christopher M; Hampton, Sally L; Feener, Edward P

Immunization and Vaccination

免疫接种和疫苗接种

Yokomizo, Hisashi; Maeda, Yasutaka; Park, Kyoungmin; Clermont, Allen C; Hernandez, Sonia L; Fickweiler, Ward; Li, Qian; Wang, Chih-Hao; Paniagua, Samantha M; Simao, Fabricio; Ishikado, Atsushi; Sun, Bei; Wu, I-Hsien; Katagiri, Sayaka; Pober, David M; Tinsley, Liane J; Avery, Robert L; Feener, Edward P; Kern, Timothy S; Keenan, Hillary A; Aiello, Lloyd Paul; Sun, Jennifer K; King, George L; Hussain, Saira

Nomenclature of factor XI and the contact system

因子XI的命名和接触系统

Schmaier, Alvin H; Emsley, Jonas; Feener, Edward P; Gailani, David; Govers-Riemslag, José W P; Kaplan, Allen P; Maas, Coen; Morrissey, James H; Renné, Thomas; Sidelmann, Johannes J; Meijers, Joost C M

Evaluating anesthetic protocols for functional blood flow imaging in the rat eye

评估大鼠眼部功能性血流成像的麻醉方案

Moult, Eric M; Choi, WooJhon; Boas, David A; Baumann, Bernhard; Clermont, Allen C; Feener, Edward P; Fujimoto, James G

Negatively charged silver nanoparticles cause retinal vascular permeability by activating plasma contact system and disrupting adherens junction

带负电荷的银纳米颗粒通过激活血浆接触系统和破坏细胞黏附连接,导致视网膜血管通透性增加。

Long, Yan-Min; Zhao, Xing-Chen; Clermont, Allen C; Zhou, Qun-Fang; Liu, Qian; Feener, Edward P; Yan, Bing; Jiang, Gui-Bin